Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuhiro Machitani

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Biological & Pharmaceutical Bulletin|March 3, 2017
Inhibition of CRISPR/Cas9-Mediated Genome Engineering by a Type I Interferon-Induced Reduction in Guide RNA ExpressionMitsuhiro Machitani, Fuminori Sakurai, Keisaku Wakabayashi, et al.
Biomaterials|March 12, 2013
A targeted adenovirus vector displaying a human fibronectin type III domain-based monobody in a fiber proteinHayato Matsui, Fuminori Sakurai, Kazufumi Katayama, et al.
Molecular Therapy Oncolytics|December 5, 2017
Suppression of Oncolytic Adenovirus-Mediated Hepatotoxicity by Liver-Specific Inhibition of NF-κBMitsuhiro Machitani, Fuminori Sakurai, Keisaku Wakabayashi, et al.
Virology Journal|December 10, 2022
Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2Mitsuhiro Machitani, Junko Takei, Mika K Kaneko, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 28, 2011
Development of an adenovirus vector lacking the expression of virus-associated RNAsMitsuhiro Machitani, Kazufumi Katayama, Fuminori Sakurai, et al.
Scientific Reports|August 19, 2018
Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administrationKyoko Tomita, Fuminori Sakurai, Shunsuke Iizuka, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 7, 2026
Elucidation of mechanisms underlying the therapeutic effects of cordycepin on pulmonary hypertension, with a focus on cell senescence and gut microbiotaGaopeng Li, Zhixin Zhao, Mitsuhiro Machitani, et al.
Molecular Therapy. Methods & Clinical Development|March 12, 2016
Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirusFuminori Sakurai, Nobuhiro Narii, Kyoko Tomita, et al.
Nature Cell Biology|May 28, 2024
Maintenance of R-loop structures by phosphorylated hTERT preserves genome integrityMitsuhiro Machitani, Akira Nomura, Taro Yamashita, et al.
Nature Communications|March 28, 2020
CDK1 dependent phosphorylation of hTERT contributes to cancer progressionMami Yasukawa, Yoshinari Ando, Taro Yamashita, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Biological & Pharmaceutical Bulletin|March 3, 2017
Inhibition of CRISPR/Cas9-Mediated Genome Engineering by a Type I Interferon-Induced Reduction in Guide RNA ExpressionMitsuhiro Machitani, Fuminori Sakurai, Keisaku Wakabayashi, et al.
Biomaterials|March 12, 2013
A targeted adenovirus vector displaying a human fibronectin type III domain-based monobody in a fiber proteinHayato Matsui, Fuminori Sakurai, Kazufumi Katayama, et al.
Molecular Therapy Oncolytics|December 5, 2017
Suppression of Oncolytic Adenovirus-Mediated Hepatotoxicity by Liver-Specific Inhibition of NF-κBMitsuhiro Machitani, Fuminori Sakurai, Keisaku Wakabayashi, et al.
Virology Journal|December 10, 2022
Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2Mitsuhiro Machitani, Junko Takei, Mika K Kaneko, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 28, 2011
Development of an adenovirus vector lacking the expression of virus-associated RNAsMitsuhiro Machitani, Kazufumi Katayama, Fuminori Sakurai, et al.
Scientific Reports|August 19, 2018
Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administrationKyoko Tomita, Fuminori Sakurai, Shunsuke Iizuka, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 7, 2026
Elucidation of mechanisms underlying the therapeutic effects of cordycepin on pulmonary hypertension, with a focus on cell senescence and gut microbiotaGaopeng Li, Zhixin Zhao, Mitsuhiro Machitani, et al.
Molecular Therapy. Methods & Clinical Development|March 12, 2016
Efficient detection of human circulating tumor cells without significant production of false-positive cells by a novel conditionally replicating adenovirusFuminori Sakurai, Nobuhiro Narii, Kyoko Tomita, et al.
Nature Cell Biology|May 28, 2024
Maintenance of R-loop structures by phosphorylated hTERT preserves genome integrityMitsuhiro Machitani, Akira Nomura, Taro Yamashita, et al.
Nature Communications|March 28, 2020
CDK1 dependent phosphorylation of hTERT contributes to cancer progressionMami Yasukawa, Yoshinari Ando, Taro Yamashita, et al.
Pageof 3